Synthetic BZLF1-targeted transcriptional activator for efficient lytic induction therapy against EBV-associated epithelial cancers.

Autor: Wu M; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, The Chinese University of Hong Kong, Hong Kong SAR, China., Hau PM; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Li L; Ming Wai Lau Centre for Reparative Medicine, Karolinska Institutet, Shatin, Hong Kong SAR, China.; Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.; Center for Neuromusculoskeletal Restorative Medicine, Hong Kong Science Park, Hong Kong SAR, China., Tsang CM; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, The Chinese University of Hong Kong, Hong Kong SAR, China., Yang Y; Ming Wai Lau Centre for Reparative Medicine, Karolinska Institutet, Shatin, Hong Kong SAR, China.; College of Chemistry and Green Catalysis Center, Zhengzhou University, Zhengzhou, China., Taghbalout A; The Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA., Chung GT; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Hui SY; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Tang WC; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Jillette N; The Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA., Zhu JJ; The Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.; School of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ, 85281, USA., Lee HHY; Ming Wai Lau Centre for Reparative Medicine, Karolinska Institutet, Shatin, Hong Kong SAR, China., Kong EL; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Chan MSA; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Chan JYK; Department of Otorhinolaryngology, Head and Neck Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Ma BBY; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Charlie Lee Precision Immuno-oncology program, Sir Y.K. Pao Centre for Cancer, The Chinese University of Hong Kong, Hong Kong SAR, China., Chen MR; Graduate Institute and Department of Microbiology, College of Medicine, National Taiwan University, Taipei, 100233, Taiwan., Lee C; The Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA., To KF; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, The Chinese University of Hong Kong, Hong Kong SAR, China., Cheng AW; The Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA. albert.cheng@ioz.ac.cn.; School of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ, 85281, USA. albert.cheng@ioz.ac.cn.; Department of Genetics and Genome Sciences, University of Connecticut Health Center, Farmington, CT, 06030, USA. albert.cheng@ioz.ac.cn.; Institute for Systems Genomics, University of Connecticut Health Center, Farmington, CT, 06030, USA. albert.cheng@ioz.ac.cn.; The Jackson Laboratory Cancer Center, Bar Harbor, ME, 04609, USA. albert.cheng@ioz.ac.cn.; State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China. albert.cheng@ioz.ac.cn.; Key Laboratory of Organ Regeneration and Reconstruction, Chinese Academy of Sciences, Beijing, China. albert.cheng@ioz.ac.cn.; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, China. albert.cheng@ioz.ac.cn.; University of Chinese Academy of Sciences, Beijing, China. albert.cheng@ioz.ac.cn., Lo KW; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China. kwlo@cuhk.edu.hk.; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, The Chinese University of Hong Kong, Hong Kong SAR, China. kwlo@cuhk.edu.hk.

Publikováno v: Nature communications [Nat Commun] 2024 May 03; Vol. 15 (1), pp. 3729. Date of Electronic Publication: 2024 May 03.

Comparison of plaque reduction and focus reduction neutralization tests for the measurement of neutralizing antibody titers against japanese encephalitis virus.

Autor: Park Y; Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea., Kim AR; Division of Vaccine Clinical Research, National Institute of Health, Korea Centers for Disease Control and Prevention Agency, CheongJu, Chungcheongbuk-do, Republic of Korea., Hwang YH; Division of Infectious Diseases Vaccine Research, National Institute of Health, Korea Centers for Disease Control and Prevention Agency, CheongJu, Chungcheongbuk-do, Republic of Korea., Yang H; Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea., Lee JW; Division of Vaccine Clinical Research, National Institute of Health, Korea Centers for Disease Control and Prevention Agency, CheongJu, Chungcheongbuk-do, Republic of Korea., Kim MY; Division of Vaccine Development Coordination, National Institute of Health, Korea Centers for Disease Control and Prevention Agency, CheongJu, Chungcheongbuk-do, Republic of Korea., Kim HS; Division of HIV/AIDS prevention and Control, Korea Diseases Control and Prevention Agency, CheongJu, Chungcheongbuk-do, Republic of Korea., Chung GT; Center for Infectious Disease, National Institute of Health, Korea Centers for Disease Control and Prevention Agency, CheongJu, Chungcheongbuk-do, Republic of Korea., Yoo JS; Division of Antimicrobial Resistance, National Institute of Health, Korea Centers for Disease Control and Prevention Agency, CheongJu, Chungcheongbuk-do, Republic of Korea., Kim YJ; Division of Infectious Diseases Vaccine Research, National Institute of Health, Korea Centers for Disease Control and Prevention Agency, CheongJu, Chungcheongbuk-do, Republic of Korea., Kim D; Division of Infectious Diseases Vaccine Research, National Institute of Health, Korea Centers for Disease Control and Prevention Agency, CheongJu, Chungcheongbuk-do, Republic of Korea., Won H; Division of Infectious Diseases Vaccine Research, National Institute of Health, Korea Centers for Disease Control and Prevention Agency, CheongJu, Chungcheongbuk-do, Republic of Korea. Electronic address: hw403@korea.kr.

Publikováno v: Journal of virological methods [J Virol Methods] 2022 Aug; Vol. 306, pp. 114540. Date of Electronic Publication: 2022 May 10.

Quantifying full-length circular RNAs in cancer.

Autor: Yu KH; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.; Department of Computer Science and Engineering, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong., Shi CH; Department of Computer Science and Engineering, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong., Wang B; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong., Chow SH; Department of Computer Science and Engineering, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.; School of Life Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong., Chung GT; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong., Lung RW; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong., Tan KE; Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur 50603, Malaysia., Lim YY; Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur 50603, Malaysia., Tsang AC; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong., Lo KW; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong., Yip KY; Department of Computer Science and Engineering, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.; Hong Kong Bioinformatics Centre, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.

Publikováno v: Genome research [Genome Res] 2021 Dec; Vol. 31 (12), pp. 2340-2353. Date of Electronic Publication: 2021 Oct 18.

Optimization of Zika DNA vaccine by delivery systems.

Autor: Lee YH; Division of Vaccine Clinical Research, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, CheongJu, Chungcheongbuk-do, Republic of Korea., Lim H; Division of Vaccine Development Coordination, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, CheongJu, Chungcheongbuk-do, Republic of Korea., Lee JA; Division of Infectious Disease Vaccine Research, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, CheongJu, Chungcheongbuk-do, Republic of Korea., Kim SH; Division of Vaccine Clinical Research, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, CheongJu, Chungcheongbuk-do, Republic of Korea., Hwang YH; Division of Infectious Disease Vaccine Research, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, CheongJu, Chungcheongbuk-do, Republic of Korea., In HJ; Division of Vaccine Development Coordination, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, CheongJu, Chungcheongbuk-do, Republic of Korea., Kim MY; Division of Vaccine Development Coordination, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, CheongJu, Chungcheongbuk-do, Republic of Korea., Chung GT; Division of Vaccine Development Coordination, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, CheongJu, Chungcheongbuk-do, Republic of Korea. Electronic address: gtchung@nih.go.kr.

Publikováno v: Virology [Virology] 2021 Jul; Vol. 559, pp. 10-14. Date of Electronic Publication: 2021 Mar 12.

Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy.

Autor: Lechner M; UCL Cancer Institute, University College London, London, UK. m.lechner@ucl.ac.uk.; Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, CA, USA. m.lechner@ucl.ac.uk.; Barts Health NHS Trust, London, UK. m.lechner@ucl.ac.uk.; Royal National Throat, Nose and Ear Hospital and Head and Neck Centre, University College London Hospitals NHS Trust, London, UK. m.lechner@ucl.ac.uk., Schartinger VH; Department of Otorhinolaryngology, Medical University of Innsbruck, Innsbruck, Austria., Steele CD; UCL Cancer Institute, University College London, London, UK., Nei WL; Divisions of Radiation Oncology and Medical Sciences, National Cancer Centre, Singapore, Singapore.; Oncology Academic Programme, Duke-NUS Medical School, Singapore, Singapore., Ooft ML; King´s College Hospitals, NHS Foundation Trust, London, UK.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Schreiber LM; Institute of Virology and Christian Doppler Laboratory for Viral Immunotherapy of Cancer, Medical University of Innsbruck, Innsbruck, Austria., Pipinikas CP; UCL Cancer Institute, University College London, London, UK., Chung GT; Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China., Chan YY; Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China., Wu F; Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China., To KF; Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China., Tsang CM; Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China., Pearce W; UCL Cancer Institute, University College London, London, UK., Morelli D; UCL Cancer Institute, University College London, London, UK., Philpott M; Botnar Research Centre, University of Oxford, Oxford, UK., Masterson L; Department of Otolaryngology, Addenbrooke's Hospital, Cambridge, UK., Nibhani R; Botnar Research Centre, University of Oxford, Oxford, UK., Wells G; Botnar Research Centre, University of Oxford, Oxford, UK., Bell CG; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Koller J; Department of Otorhinolaryngology, Medical University of Innsbruck, Innsbruck, Austria.; Botnar Research Centre, University of Oxford, Oxford, UK., Delecluse S; German Cancer Research Centre (DKFZ) and Inserm, Unit F100/U1074, Heidelberg, Germany., Yip YL; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China., Liu J; UCL Cancer Institute, University College London, London, UK., Forde CT; Royal National Throat, Nose and Ear Hospital and Head and Neck Centre, University College London Hospitals NHS Trust, London, UK., Forster MD; UCL Cancer Institute, University College London, London, UK.; Royal National Throat, Nose and Ear Hospital and Head and Neck Centre, University College London Hospitals NHS Trust, London, UK., Jay A; Department of Histopathology, University College London Hospitals NHS Trust, Euston Road, London, UK., Dudás J; Department of Otorhinolaryngology, Medical University of Innsbruck, Innsbruck, Austria., Krapp A; Department of Otorhinolaryngology, Medical University of Innsbruck, Innsbruck, Austria., Wan S; Institute of Nuclear Medicine, University College Hospital, Euston Road, London, UK., Uprimny C; Department of Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria., Sprung S; Department of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Austria., Haybaeck J; Department of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Austria.; Diagnostic & Research Center for Molecular Biomedicine, Institute of Pathology, Medical University of Graz, Graz, Austria., Fenton TR; School of Biosciences, University of Kent, Canterbury, UK., Chester K; UCL Cancer Institute, University College London, London, UK., Thirlwell C; UCL Cancer Institute, University College London, London, UK.; University of Exeter College of Medicine and Health, Exeter, UK., Royle G; UCL Cancer Institute, University College London, London, UK., Marafioti T; UCL Cancer Institute, University College London, London, UK., Gupta R; UCL Cancer Institute, University College London, London, UK., Indrasari SR; ENT Head and Neck Surgery Department, Universitas Gadjah Mada, Dr. Sardjito Hospital, Yogyakarta, Indonesia., Herdini C; ENT Head and Neck Surgery Department, Universitas Gadjah Mada, Dr. Sardjito Hospital, Yogyakarta, Indonesia., Slim MAM; Department of Ear, Nose and Throat, University Hospital Crosshouse, Crosshouse, Kilmarnock, UK., Indrawati I; Department of Anatomical Pathology, Universitas Gadjah Mada, Dr. Sardjito Hospital, Yogyakarta, Indonesia., Sutton L; Barts Health NHS Trust, London, UK., Fles R; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Tan B; ENT Head and Neck Surgery Department, Universitas Gadjah Mada, Dr. Sardjito Hospital, Yogyakarta, Indonesia.; Department of ENT/Head and Neck Surgery, Maastricht University Medical Center (MUMC), Maastricht, The Netherlands., Yeong J; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.; Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore., Jain A; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore., Han S; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore., Wang H; Divisions of Radiation Oncology and Medical Sciences, National Cancer Centre, Singapore, Singapore., Loke KSH; Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, Singapore, Singapore., He W; Department of Oncology, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China., Xu R; Department of Oncology, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China., Jin H; Department of Pathology, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China., Cheng Z; Department of Pathology, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, Shenzhen, Guangdong, China., Howard D; Royal National Throat, Nose and Ear Hospital and Head and Neck Centre, University College London Hospitals NHS Trust, London, UK.; ENT Department, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK., Hwang PH; Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, CA, USA., Le QT; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA, USA., Tay JK; Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA.; Department of Otolaryngology-Head and Neck Surgery, National University of Singapore, Singapore, Singapore., West RB; Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA., Tsao SW; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China., Meyer T; UCL Cancer Institute, University College London, London, UK., Riechelmann H; Department of Otorhinolaryngology, Medical University of Innsbruck, Innsbruck, Austria., Oppermann U; Botnar Research Centre, University of Oxford, Oxford, UK.; Freiburg Institute for Advanced Studies (FRIAS), University of Freiburg, 79085, Freiburg, Germany., Delecluse HJ; German Cancer Research Centre (DKFZ) and Inserm, Unit F100/U1074, Heidelberg, Germany., Willems SM; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Pathology, University Medical Center Groningen, Groningen, The Netherlands., Chua MLK; Divisions of Radiation Oncology and Medical Sciences, National Cancer Centre, Singapore, Singapore.; Oncology Academic Programme, Duke-NUS Medical School, Singapore, Singapore., Busson P; CNRS-UMR 9018-METSY, Gustave Roussy and Université Paris-Saclay, Villejuif, France., Lo KW; Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China., Wollmann G; Institute of Virology and Christian Doppler Laboratory for Viral Immunotherapy of Cancer, Medical University of Innsbruck, Innsbruck, Austria., Pillay N; UCL Cancer Institute, University College London, London, UK.; Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, UK., Vanhaesebroeck B; UCL Cancer Institute, University College London, London, UK. bart.vanh@ucl.ac.uk., Lund VJ; UCL Cancer Institute, University College London, London, UK. v.lund@ucl.ac.uk.; Royal National Throat, Nose and Ear Hospital and Head and Neck Centre, University College London Hospitals NHS Trust, London, UK. v.lund@ucl.ac.uk.

Publikováno v: Nature communications [Nat Commun] 2021 Jan 05; Vol. 12 (1), pp. 117. Date of Electronic Publication: 2021 Jan 05.